Companies / Heartflow, Inc.
Heartflow, Inc.
Nasdaq: HTFLCIK 1464521SAN FRANCISCO, CA
Financials · FY2025
Ownership
86.2M shares outstanding · as of Apr 30, 2026
Ownership
| Insiders | 1.56% | 1,347,829 |
| 10%+ / strategic | 12.12% | 10,448,158 |
| Institutions | 57.83% | 49,875,588 |
| Public float | 28.49% | 24,569,253 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
| 12.12% | 10,448,158 | |
Farquhar John C.M.CEOChief Executive Officer · Director | 0.66% | 571,725 |
Lightcap Jeffrey CDirector | 0.29% | 246,261 |
Verghese VikramChief Financial Officer | 0.25% | 212,863 |
Barabe Timothy CDirector | 0.21% | 179,521 |
Rogers CampbellChief Medical Officer | 0.09% | 78,518 |
Jones Marie L.Chief Accounting Officer, VP | 0.04% | 31,650 |
Cullivan Julie ADirector | 0.03% | 27,291 |
HealthCor Partners Management LPDirector | 0.00% | 0 |
| — | — |
Institutional holders 130
View all →| Holder | Value | % of shares |
|---|---|---|
| $362.86M | 14.43% | |
| $171.81M | 6.83% | |
| $152.50M | 6.03% | |
| $120.18M | 4.78% | |
| $93.12M | 4.44% | |
| $56.53M | 2.25% | |
| $53.06M | 2.53% | |
| $48.18M | 1.93% | |
| $46.07M | 1.83% | |
| $43.27M | 1.70% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Sell | Common Stock | $56.10M | -2.0M -16.07% | 10,448,158 12.12% of shares | high |
| Mar 19, 2026 | Rogers Campbell Executive | Sell | Common Stock | $1.66M | -65K -45.11% | 78,518 0.09% of shares | medium |
| Feb 12, 2026 | Rogers Campbell Executive | Sell | Common Stock | $1.60M | -65K -46.15% | 76,034 0.09% of shares | medium |
| Feb 10, 2026 | Farquhar John C.M. CEO | Sell | Common Stock | $619.6K | -23K -3.67% | 591,656 0.69% of shares | medium |
| Feb 12, 2026 | Rogers Campbell Executive | Exercise | Common Stock | $330.8K | +40K +42.44% | 133,281 0.15% of shares | low |
| Mar 10, 2026 | Farquhar John C.M. CEO | Sell | Common Stock | $290.9K | -13K -2.16% | 581,450 0.67% of shares | medium |
| Mar 18, 2026 | Farquhar John C.M. CEO | Sell | Common Stock | $243.1K | -10K -1.67% | 571,725 0.66% of shares | medium |
| Mar 5, 2026 | Cullivan Julie A Director | Sell | Common Stock | $228.1K | -9K -25.05% | 27,291 0.03% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Wellington Management Group LLP | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| HealthCor Partners Management LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| HTFL | — | 42238D107 |